Arcadia Biosciences Inc Total Assets
Arcadia Biosciences Inc total assets. Based on the latest financial reports, Arcadia Biosciences Inc (RKDA) holds total assets worth $6.55 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Arcadia Biosciences Inc stock valuation for the company's overall valuation and market capitalisation.
Total Assets of Arcadia Biosciences Inc (2012–2025)
Total assets of Arcadia Biosciences Inc from 2012 to 2025. This chart illustrates how Arcadia Biosciences Inc's total assets have evolved over time, based on quarterly financial data. See current stock price of Arcadia Biosciences Inc for real-time trading data and today's change.
Arcadia Biosciences Inc - Asset Composition Analysis
Arcadia Biosciences Inc Total Assets Breakdown (December 2025)
Arcadia Biosciences Inc total assets breakdown as of December 2025. Arcadia Biosciences Inc's total assets of $6.55 Million consist of 97.1% current assets and 2.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 4.0% |
| Accounts Receivable | $425.00K | 6.5% |
| Inventory | $1.21 Million | 18.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $39.00K | 0.6% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2012–2025)
This chart illustrates how Arcadia Biosciences Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore RKDA working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Arcadia Biosciences Inc's current assets represent 97.1% of total assets in 2025, an increase from 59.0% in 2012.
- Cash Position: Cash and equivalents constituted 4.0% of total assets in 2025, down from 40.1% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 18.5% of total assets.
Arcadia Biosciences Inc Competitors by Total Assets
Key competitors of Arcadia Biosciences Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Nestle S.A.
SW:NESN
|
Switzerland | CHF128.38 Billion |
|
Inner Mongolia Yili Industrial Group Co Ltd
SHG:600887
|
China | CN¥157.17 Billion |
|
Guangdong Haid Group Co Ltd
SHE:002311
|
China | CN¥55.29 Billion |
|
Tingyi (Cayman Islands) Holding Corp
F:TYG
|
Germany | €54.94 Billion |
|
JBS N.V.
NYSE:JBS
|
USA | $248.34 Billion |
|
Tai Roun Products Co Ltd
TW:1220
|
Taiwan | NT$3.53 Billion |
|
Thai President Foods Public Company Limited
BK:TFMAMA
|
Thailand | ฿51.06 Billion |
|
Unibel S.A
PA:UNBL
|
France | €4.09 Billion |
Arcadia Biosciences Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.09 | 3.61 | 10.08 |
| Quick Ratio | 2.50 | 3.25 | 9.60 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $4.30 Million | $6.68 Million | $51.00 Million |
Arcadia Biosciences Inc - Advanced Valuation Insights
This section examines the relationship between Arcadia Biosciences Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.53 |
| Latest Market Cap to Assets Ratio | 0.05 |
| Asset Growth Rate (YoY) | -51.6% |
| Total Assets | $6.55 Million |
| Market Capitalization | $320.87K USD |
Valuation Analysis
Below Book Valuation: The market values Arcadia Biosciences Inc's assets below their book value (0.05x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Arcadia Biosciences Inc's assets decreased by 51.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Arcadia Biosciences Inc (2012–2025)
The table below shows the annual total assets of Arcadia Biosciences Inc from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $6.55 Million | -51.57% |
| 2024-12-31 | $13.52 Million | -31.40% |
| 2023-12-31 | $19.70 Million | -31.87% |
| 2022-12-31 | $28.92 Million | -34.15% |
| 2021-12-31 | $43.92 Million | -7.24% |
| 2020-12-31 | $47.35 Million | +45.36% |
| 2019-12-31 | $32.57 Million | +35.59% |
| 2018-12-31 | $24.02 Million | +44.98% |
| 2017-12-31 | $16.57 Million | -70.71% |
| 2016-12-31 | $56.57 Million | -23.80% |
| 2015-12-31 | $74.24 Million | +198.29% |
| 2014-12-31 | $24.89 Million | +160.84% |
| 2013-12-31 | $9.54 Million | -28.57% |
| 2012-12-31 | $13.36 Million | -- |
About Arcadia Biosciences Inc
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief,… Read more